Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




NIH Extends Collaboration for HIV Diagnostics

By HospiMedica staff writers
Posted on 09 Apr 2007
Human immunosuppressive virus (HIV) diagnostics are important to maintaining the safety of the blood supply through donor screening and by providing early diagnosis and monitoring of HIV infection so that patients may benefit from early treatment regimens.

The U.S. More...
National Institutes of Health (NIH; Bethesda, MD, USA), an agency of the U.S. Department of Health and Human Services, and Institut Pasteur (IP; Paris, France), a private non-profit foundation, announced an agreement to extend their long-standing collaboration in health research and the management of inventions arising from this research. These two institutions have been leaders and collaborators in the field of HIV/AIDS research for more than 20 years. The extended agreement will initially facilitate the patenting and licensing of a large portfolio of intellectual property held by NIH and IP in the field of HIV-1 diagnostics. Additional long-term public health benefits are expected as the agreement provides a new framework for further support and encouragement of collaborative research in a variety of areas by leading scientists at both the NIH and IP.

To date, effective HIV-1 diagnostic test kits based upon technology licensed from IP and NIH has been distributed worldwide by many companies, saving millions of lives. As the science of understanding the HIV-1 virus has progressed, new technologies arising from the laboratories of IP and NIH and subsequently developed by diagnostics companies now allow these tests to be provided with increased sensitivity and specificity but at a lower cost.

According to the latest figures published an estimated 39.5 million people are living with HIV. There were 4.3 million new infections in 2006 with 2.8 million (65%) of these occurring in sub-Saharan Africa and important increases in Eastern Europe and Central Asia, where there are some indications that infection rates have risen by more than 50% since 2004. In 2006, 2.9 million people died of AIDS-related illnesses.

Institut Pasteur is dedicated to the prevention and treatment of diseases through research, education, and public health activities. A large part of Institut Pasteur's research activities is devoted to infectious diseases with important efforts on AIDS research.


Related Links:
U.S. National Institutes of Health
Institut Pasteur

Gold Member
Blood Gas Analyzer
i-Check200
Radiology Monitor
MDNC-6121 Barco Nio Color 5.8MP
Hypodermic Syringe
SurTract™ Safety Syringe
Blood Pressure Monitor
Cuff Blood Pressure Monitor
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to HospiMedica.com and get access to news and events that shape the world of Hospital Medicine.
  • Free digital version edition of HospiMedica International sent by email on regular basis
  • Free print version of HospiMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of HospiMedica International in digital format
  • Free HospiMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Surgical Techniques

view channel
Image: New findings show that chemotherapy plus immunotherapy before surgery produced greater tumor destruction than immunotherapy alone in head and neck cancer patients (Image Credit: Adobe Stock)

Combination Therapy Before Surgery Drives Stronger Tumor Reduction in Head and Neck Cancer

Patients with head and neck cancer who are scheduled for surgery often face a waiting period with limited treatment, creating an opportunity to reduce viable tumor burden before the operation.... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.